[Systemic treatment of acne: proposal. The French Agency of Sanitary Safety of Health Products].
D000152:Acne Vulgaris / Q000145:classification / Q000188:drug therapy* / Q000473:pathology; D000284:Administration, Oral; D000726:Androgen Antagonists / Q000008:administration & dosage / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use; D017373:Cyproterone Acetate / Q000008:administration & dosage / Q000627:therapeutic use; D003879:Dermatologic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D045166:Estradiol Congeners / Q000008:administration & dosage / Q000627:therapeutic use; D004997:Ethinyl Estradiol / Q000008:administration & dosage / Q000627:therapeutic use; D005500:Follow-Up Studies; D005942:Gluconates / Q000627:therapeutic use; D006801:Humans; D015474:Isotretinoin / Q000008:administration & dosage / Q000627:therapeutic use; D007641:Keratolytic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D008094:Lithium / Q000008:administration & dosage / Q000627:therapeutic use; D015032:Zinc / Q000008:administration & dosage / Q000627:therapeutic use
D000726:Androgen Antagonists; D000900:Anti-Bacterial Agents; D003879:Dermatologic Agents; D045166:Estradiol Congeners; D005942:Gluconates; D007641:Keratolytic Agents; D004997:Ethinyl Estradiol; D017373:Cyproterone Acetate; D008094:Lithium; D015474:Isotretinoin; D015032:Zinc; C030691:gluconic acid
Traitement de l'acné par voie générale: argumentaire. Agence Française de Securite Sanitaire des Produits de Sante.